ArticlePharmaceutics2021

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice.

Songyi Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.